Susquehanna International Group’s Compass Therapeutics CMPX Stock Holding History
Bought
Maintained
Sold
Other funds holding CMPX
Susquehanna International Group's CMPX Position: Q3 2026 in Review
Susquehanna International Group increased its Compass Therapeutics (CMPX) stake by 152% in Q3 2026, buying an estimated $964K and bringing the position to 775,923 shares worth $807K. The position accounts for ﹤0.01% of the portfolio, ranked #8513.
Susquehanna International Group first reported a position in CMPX in Q3 2022 and has held it in 15 quarters since. The position peaked at $2.56M in Q1 2023. 172 funds tracked by Wall St. Rank hold CMPX as of Q3 2026.
- Susquehanna International Group held 775,923 shares of Compass Therapeutics worth $807K as of Q3 2026.
- Susquehanna International Group bought 467,628 Compass Therapeutics shares in Q3 2026, an estimated $964K.
- Compass Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q3 2026, its #8513 holding.
- Susquehanna International Group first reported a position in Compass Therapeutics in Q3 2022 and has held it in 15 quarters since.
- Susquehanna International Group's Compass Therapeutics position peaked at $2.56M in Q1 2023.
- 172 funds tracked by Wall St. Rank held Compass Therapeutics as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.